In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Corteva’s current price at $9.19 trades significantly below its PERT-weighted fair value of $66.20, indicating substantial undervaluation with high confidence. However, low profitability (1/5) and high leverage (5/5) increase financial risk. Monte Carlo analysis shows high volatility but no downside scenarios below the current price, reflecting risk with growth opportunity.